Completed NA INTERVENTIONAL 1-arm NCT02914145

Mass Drug Administrations of DHA-PQP to Accelerate Towards Malaria Elimination in Magude District, Southern Mozambique (MDAM)

Mass Drug Administration of Monthly DHA-PQP to Accelerate Towards Malaria Elimination in Magude District, Southern Mozambique

Sponsor: Barcelona Institute for Global Health

Conditions Malaria

Interventions Dihydroartemisinin-piperaquine

Updated 6 times since 2017 Last updated: Feb 5, 2018 Started: Nov 30, 2015 Primary completion: Dec 31, 2017 Completion: Dec 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02914145, this NA trial focuses on Malaria and remains completed. Sponsored by Barcelona Institute for Global Health, it has been updated 6 times since 2015, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Mar 2018 — Jun 2018 [monthly]

Completed NA

Status: Active Not Recruiting → Completed

▶ Show 1 earlier version

Jan 2017 — Mar 2018 [monthly]

Active Not Recruiting NA

First recorded

Nov 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Barcelona Institute for Global Health
Centro de Investigacao em Saude de Manhica

Data source: Centro de Investigacao em Saude de Manhica

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.